These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 17911170

  • 1. Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults.
    Oliveira JL, Aguiar-Oliveira MH, D'Oliveira A, Pereira RM, Oliveira CR, Farias CT, Barreto-Filho JA, Anjos-Andrade FD, Marques-Santos C, Nascimento-Junior AC, Alves EO, Oliveira FT, Campos VC, Ximenes R, Blackford A, Parmigiani G, Salvatori R.
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4664-70. PubMed ID: 17911170
    [Abstract] [Full Text] [Related]

  • 2. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R, Gunczler P, Lopez E, Esaa S, Villaroel O, Revel-Chion R.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [Abstract] [Full Text] [Related]

  • 3. Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency.
    Colao A, Di Somma C, Rota F, Pivonello R, Savanelli MC, Spiezia S, Lombardi G.
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2056-62. PubMed ID: 15671089
    [Abstract] [Full Text] [Related]

  • 4. Arrest of atherosclerosis progression after interruption of GH replacement in adults with congenital isolated GH deficiency.
    Araujo VP, Aguiar-Oliveira MH, Oliveira JL, Rocha HM, Oliveira CR, Rodrigues TM, Nunes MA, Britto IM, Ximenes R, Barreto-Filho JA, Meneguz-Moreno RA, Pereira RM, Valença EH, Oliveira-Neto LA, Vicente TA, Blackford A, Salvatori R.
    Eur J Endocrinol; 2012 Jun; 166(6):977-82. PubMed ID: 22416078
    [Abstract] [Full Text] [Related]

  • 5. Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency.
    Colao A, Di Somma C, Cuocolo A, Spinelli L, Acampa W, Spiezia S, Rota F, Savanelli MC, Lombardi G.
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5146-55. PubMed ID: 15985481
    [Abstract] [Full Text] [Related]

  • 6. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.
    Colao A, di Somma C, Pivonello R, Cuocolo A, Spinelli L, Bonaduce D, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170
    [Abstract] [Full Text] [Related]

  • 7. The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis.
    Colao A, Di Somma C, Spiezia S, Rota F, Pivonello R, Savastano S, Lombardi G.
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2191-200. PubMed ID: 16537686
    [Abstract] [Full Text] [Related]

  • 8. Lack of evidence of premature atherosclerosis in untreated severe isolated growth hormone (GH) deficiency due to a GH-releasing hormone receptor mutation.
    Menezes Oliveira JL, Marques-Santos C, Barreto-Filho JA, Ximenes Filho R, de Oliveira Britto AV, Oliveira Souza AH, Prado CM, Pereira Oliveira CR, Pereira RM, Ribeiro Vicente Tde A, Farias CT, Aguiar-Oliveira MH, Salvatori R.
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2093-9. PubMed ID: 16522693
    [Abstract] [Full Text] [Related]

  • 9. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
    Salerno M, Esposito V, Spinelli L, Di Somma C, Farina V, Muzzica S, de Horatio LT, Lombardi G, Colao A.
    Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
    [Abstract] [Full Text] [Related]

  • 10. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
    Abs R, Feldt-Rasmussen U, Mattsson AF, Monson JP, Bengtsson BA, Góth MI, Wilton P, Koltowska-Häggström M.
    Eur J Endocrinol; 2006 Jul; 155(1):79-90. PubMed ID: 16793953
    [Abstract] [Full Text] [Related]

  • 11. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
    Elgzyri T, Castenfors J, Hägg E, Backman C, Thorén M, Bramnert M.
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
    [Abstract] [Full Text] [Related]

  • 12. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency.
    Colao A, di Somma C, Cuocolo A, Spinelli L, Tedesco N, Pivonello R, Bonaduce D, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 2001 May; 86(5):1874-81. PubMed ID: 11344175
    [Abstract] [Full Text] [Related]

  • 13. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C, Colao A.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults.
    Pfeifer M, Verhovec R, Zizek B, Prezelj J, Poredos P, Clayton RN.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):453-7. PubMed ID: 10022400
    [Abstract] [Full Text] [Related]

  • 15. Carotid artery intima-media thickness and lipid profile in adults with growth hormone deficiency after long-term growth hormone replacement.
    Soares DV, Spina LD, de Lima Oliveira Brasil RR, da Silva EM, Lobo PM, Salles E, Coeli CM, Conceição FL, Vaisman M.
    Metabolism; 2005 Mar; 54(3):321-9. PubMed ID: 15736109
    [Abstract] [Full Text] [Related]

  • 16. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.
    Bengtsson BA, Abs R, Bennmarker H, Monson JP, Feldt-Rasmussen U, Hernberg-Stahl E, Westberg B, Wilton P, Wüster C.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3929-35. PubMed ID: 10566630
    [Abstract] [Full Text] [Related]

  • 17. Common carotid intima-media thickness in growth hormone (GH)-deficient adolescents: a prospective study after GH withdrawal and restarting GH replacement.
    Colao A, Di Somma C, Rota F, Di Maio S, Salerno M, Klain A, Spiezia S, Lombardi G.
    J Clin Endocrinol Metab; 2005 May; 90(5):2659-65. PubMed ID: 15713715
    [Abstract] [Full Text] [Related]

  • 18. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
    Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW, Hurley D.
    J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
    [Abstract] [Full Text] [Related]

  • 19. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
    Johannsson G, Albertsson-Wikland K, Bengtsson BA.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone and the risk of atherosclerosis in growth hormone-deficient children.
    Binay C, Simsek E, Yıldırım A, Kosger P, Demiral M, Kılıç Z.
    Growth Horm IGF Res; 2015 Dec; 25(6):294-7. PubMed ID: 26296621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.